Blood Platelets Market By Platelet Type (Whole-blood Derived Platelets, Apheresis-derived Platelets); By Application (Thrombocytopenia, Platelet Function Disorders, Perioperative Indications, Hematologic / Bleeding Disorders); By End User (Hospitals, Ambulatory Surgical Centers, Other End Users); By Region – Growth, Share, Opportunities & Competitive Analysis, 2025 – 2032
The global Blood Platelets Market size was estimated at USD 6154.6 million in 2025 and is expected to reach USD 8044.68 million by 2032, growing at a CAGR of 3.9% from 2025 to 2032. Demand expansion is primarily supported by sustained platelet utilization across hematology and oncology care pathways, where prophylactic and therapeutic transfusions remain routine for thrombocytopenia management and bleeding risk reduction. Blood Platelets Market growth is also supported by continued modernization of blood center processing and hospital transfusion services, which improves component availability and reduces wastage in high-throughput settings.
REPORT ATTRIBUTE
DETAILS
Historical Period
2020-2024
Base Year
2025
Forecast Period
2026-2032
Blood Platelets Market Size 2025
USD 6154.6 million
Blood Platelets Market, CAGR
3.9%
Blood Platelets Market Size 2032
USD 8044.68 million
Key Market Trends & Insights
The Blood Platelets Market is projected to expand at a CAGR of 3.9% during 2025–2032.
Apheresis-derived Platelets accounted for the largest share of 52.4% in 2025 due to controlled dosing and higher collection yields.
Thrombocytopenia represented 40.1% share in 2025, reflecting the large prophylactic transfusion base in routine inpatient care.
Hospitals held 76.8% share in 2025 as hospitals concentrate transfusion-intensive specialties and emergency demand.
Asia Pacific accounted for 29.1% share in 2025, supported by scale effects and increasing access to transfusion medicine.
Segment Analysis
Blood Platelets Market performance is closely tied to transfusion intensity in hospital-based care and the ability of blood services to maintain reliable platelet availability despite short shelf life and stringent storage requirements. Clinical practice patterns continue to anchor platelet demand, especially for thrombocytopenia management, perioperative coverage in high-bleed-risk procedures, and hematologic bleeding disorders requiring supportive transfusion care. Operational improvements in collection, processing, and inventory management are therefore critical levers shaping supply stability and procurement decisions.
Blood Platelets Market segment dynamics also reflect a gradual shift toward more standardized and controlled component workflow, where consistent dosing and reduced variability are valued by high-volume transfusion services. Apheresis-derived collections and technology-enabled processing approaches support tighter quality control and improved alignment with patient-specific dosing practices. In parallel, end-user demand remains concentrated in hospital settings due to the need for immediate access, round-the-clock transfusion support, and integrated blood bank operations.
By Platelet Type Insights
Apheresis-derived Platelets accounted for the largest share of 52.4% in 2025. Apheresis-derived Platelets lead because apheresis procedures enable higher yield per donor session and help maintain predictable supply for transfusion-heavy departments. Apheresis-derived Platelets also support more consistent dosing and quality control, which aligns with hospital blood management practices. Apheresis-derived Platelets benefit from compatibility with automated processing and scaling in large blood centers that prioritize throughput and waste reduction.
By Application Insights
Thrombocytopenia accounted for the largest share of 40.1% in 2025. Thrombocytopenia leads because prophylactic transfusion remains a routine pathway in hematology and oncology to reduce spontaneous bleeding risk in low platelet count scenarios. Thrombocytopenia demand is reinforced by inpatient management protocols that require rapid response capacity and continuous availability of platelet components. Thrombocytopenia utilization is also supported by recurring admissions and treatment cycles that create steady baseline consumption in tertiary and specialty centers.
By End User Insights
Hospitals accounted for the largest share of 76.8% in 2025. Hospitals lead because hospitals concentrate the highest volumes of transfusion-intensive care across oncology, trauma, complex surgery, and critical care. Hospitals also require immediate inventory access and strong cold-chain governance, making hospital-based blood bank systems the dominant distribution point for platelet use. Hospitals further benefit from established clinical governance and transfusion committees that standardize utilization, sustain procurement cycles, and support demand stability.
Blood Platelets Market Drivers
Rising transfusion intensity in hematology and oncology care
Blood Platelets Market growth is driven by sustained platelet use in hematology and oncology, where thrombocytopenia management remains a routine supportive therapy. Blood Platelets Market demand increases as inpatient and day-care infusion centers handle higher treatment volumes that carry platelet depletion and bleeding risks. Blood Platelets Market adoption benefits from standardized transfusion triggers and established hospital protocols that sustain baseline utilization. Blood Platelets Market demand is reinforced by repeat treatment cycles that create recurring platelet needs across large hospital networks.
For instance, an analysis from Germany found that approximately 75% of all platelet concentrates are transfused to hematology and oncology patients, reflecting the central role of platelets in these services. Blood Platelets Market demand increases as inpatient and day-care infusion centers handle higher treatment volumes that carry platelet depletion and bleeding risks.
Expansion of surgical and perioperative platelet coverage requirements
Blood Platelets Market expansion is supported by perioperative indications where platelet transfusion is used to manage bleeding risk during major procedures. Blood Platelets Market demand rises as surgical volumes expand in tertiary centers and complex cases concentrate in multidisciplinary hospitals. Blood Platelets Market utilization increases where clinicians prioritize maintaining hemostatic stability for high-risk patients. Blood Platelets Market performance is further influenced by clinical efforts to reduce transfusion delays, which favors stronger inventory planning and stable purchasing cycles.
For instance, a large cohort of 12,043 adults undergoing cardiac surgery at a U.S. tertiary hospital showed that 13.5% received leukoreduced apheresis platelets in the immediate perioperative intensive care period. Blood Platelets Market demand rises as surgical volumes expand in tertiary centers and complex cases concentrate in multidisciplinary hospitals.
Modernization of blood center collection and processing workflows
Blood Platelets Market growth is supported by operational modernization across blood centers that improves component throughput and reduces wastage. Blood Platelets Market supply reliability improves when automated processing and standardized workflows reduce variability and improve yield management. Blood Platelets Market adoption is strengthened when blood services can deliver consistent platelet quality and dosing to hospitals with predictable schedules. Blood Platelets Market growth benefits from technology-driven performance improvements that enable blood centers to meet hospital service-level expectations.
Increasing emphasis on quality control, safety, and standardization
Blood Platelets Market demand is strengthened by institutional focus on standardization, traceability, and consistent component quality across transfusion systems. Blood Platelets Market buyers increasingly prioritize validated processing, controlled storage conditions, and reliable product availability due to the time-sensitive nature of platelet transfusion. Blood Platelets Market growth is supported when blood services adopt best practices that improve confidence in platelet supply and reduce substitution with alternative therapies. Blood Platelets Market performance improves as provider systems align transfusion governance with patient safety and inventory discipline.
Blood Platelets Market Challenges
Blood Platelets Market growth faces structural constraints due to platelet shelf-life limitations, which create high wastage risk and complex inventory planning. Blood Platelets Market supply can become strained when donation rates fluctuate or when collection capacity fails to keep pace with demand spikes from surgery and oncology loads. Blood Platelets Market operations also require strict storage and handling protocols, raising logistics costs and increasing the probability of expiry-related losses when forecasting is imperfect.
Blood Platelets Market expansion is challenged by variability in transfusion practices and hospital-level utilization discipline, which can lead to inconsistent demand patterns across regions and facilities. Blood Platelets Market stakeholders must also manage regulatory and quality compliance burdens that can slow workflow changes and increase operational overhead. Blood Platelets Market participants often face procurement pressure from hospitals seeking cost containment, which intensifies competition and reduces pricing flexibility despite rising operational complexity.
For instance, a multicenter observational study across 22 US hospital sites found that 22–42% of platelet transfusions were potentially unnecessary, driven mainly by prophylactic transfusions at platelet count thresholds above guideline recommendations, underscoring substantial practice variability.
Market Trends and Opportunities
Blood Platelets Market opportunities are increasing with broader adoption of technology-enabled processing, including automation and standard workflow designs that improve yield management and reduce waste. Blood Platelets Market procurement increasingly favors solutions that support predictable throughput and stable delivery schedules to hospital transfusion services. Blood Platelets Market participants can differentiate by enabling better inventory visibility and improving component standardization across multi-site health systems.
For instance, Terumo BCT’s Reveos system uses automated whole blood processing with a Platelet Yield Index feature, and in an observational study its T‑pool Select tool helped improve platelet yields while maintaining leukoreduction quality with white blood cell levels below 1×106 per unit, reducing component variability and waste.
Blood Platelets Market trends also include strengthening collaboration models between blood centers and hospitals to align demand planning, reduce expiry, and improve service performance. Blood Platelets Market growth can be supported by expanding access to advanced transfusion practices in developing healthcare systems where procedural volumes are rising. Blood Platelets Market participants can capture opportunities by tailoring supply strategies to regional infrastructure maturity and by supporting capability building for safe storage, handling, and transfusion governance.
Regional Insights
North America
North America accounted for 27.3% share in 2025, supported by established blood services infrastructure and high concentration of transfusion-intensive hospital care. Blood Platelets Market demand in North America remains stable due to strong surgical volumes, oncology workloads, and mature transfusion governance. Blood Platelets Market supply performance in North America is influenced by modernization initiatives that improve processing efficiency and reduce wastage.
Europe
Europe represented 27.4% share in 2025, underpinned by regulated transfusion systems and widespread hospital access to component therapy. Blood Platelets Market demand in Europe is supported by high clinical adherence, strong quality requirements, and stable utilization across tertiary and regional hospitals. Blood Platelets Market growth in Europe is influenced by ongoing optimization of blood center networks and hospital inventory management programs.
Asia Pacific
Asia Pacific accounted for 29.1% share in 2025, reflecting large population scale and growing procedural volumes across major healthcare systems. Blood Platelets Market demand in Asia Pacific is supported by improving hospital capacity, expanding oncology treatment access, and broader adoption of transfusion medicine practices. Blood Platelets Market growth in Asia Pacific is shaped by investments in collection infrastructure, processing capabilities, and supply-chain reliability.
Latin America
Latin America held 8.6% share in 2025, supported by expanding hospital networks and gradual improvements in surgical capacity and transfusion access. Blood Platelets Market growth in Latin America is influenced by expanding coverage and adoption of standardized blood service practices. Blood Platelets Market demand in Latin America remains more concentrated in large metropolitan hospitals where transfusion services are more consistently available.
Middle East & Africa
Middle East & Africa accounted for 7.6% share in 2025, shaped by uneven donation rates, infrastructure maturity differences, and variable access to transfusion services. Blood Platelets Market demand is concentrated in higher-capacity urban hospitals and referral centers. Blood Platelets Market expansion in Middle East & Africa is linked to stepwise improvements in blood service organization, storage capabilities, and hospital transfusion governance.
Competitive Landscape
Blood Platelets Market competition is defined by technology-enabled processing, supply reliability, and differentiated solutions that improve throughput and reduce wastage across blood centers and hospital blood banks. Blood Platelets Market participants compete on workflow efficiency, product consistency, and operational integration with transfusion services that require tight quality control and dependable delivery schedules. Blood Platelets Market positioning is also influenced by partnerships with blood service organizations, multi-site hospital systems, and procurement groups that prefer scalable and standardized approaches.
Terumo Corporation competitive positioning in the Blood Platelets Market is supported by technology-enabled blood component processing and workflow modernization that targets improved efficiency and stability in platelet supply. Terumo Corporation strategy emphasizes solutions that align with blood center operational needs, including standardization, throughput improvement, and reduction of platelet processing variability. Terumo Corporation also benefits from geographic expansion and localization efforts that strengthen regional access and supply resilience for transfusion ecosystems.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Terumo Corporation
Fresenius Kabi
Grifols, S.A.
Cerus Corporation
Macopharma
CSL Behring
Octapharma AG
Biotest AG
Hemanext Inc.
Cellphire Inc.
American Red Cross
Sanquin
Canadian Blood Services
Vitalant
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
In March 2026, Cerus Corporation detailed that its INTERCEPT platelet franchise remains the core of its business, emphasizing a strategic growth plan built around its partnership with Blood Centers of America to potentially raise U.S. market share above 70% and extend platelet shelf life to six or seven days, thereby enhancing availability and economics in the blood platelets market.
In January 2026, Cerus Corporation also reported preliminary full‑year 2025 product revenue growth driven by global platelet product expansion and the EMEA launch of the INT200 platelet processing set within the INTERCEPT Blood System portfolio, underscoring continued adoption of pathogen‑reduced platelet components.
In May 2025, Juventix Regenerative Medical entered a strategic corporate partnership with Juvasonic to combine Juventix’s platelet-rich plasma (PRP) biologics with Juvasonic’s FDA-cleared, needle-free transdermal delivery device, broadening Juventix’s regenerative product portfolio and improving patient-friendly administration of PRP-based therapies.
Report Scope
Report Attribute
Details
Market size value in 2025
USD 6,154.6 million
Revenue forecast in 2032
USD 8,044.68 million
Growth rate (CAGR)
3.9% (2025–2032)
Base year
2025
Forecast period
2026–2032
Quantitative units
USD million
Segments covered
By Platelet Type: Whole-blood Derived Platelets, Apheresis-derived Platelets; By Application: Thrombocytopenia, Platelet Function Disorders, Perioperative Indications, Hematologic / Bleeding Disorders; By End User: Hospitals, Ambulatory Surgical Centers, Other End Users
Regional scope
North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Key companies profiled
Terumo Corporation; Fresenius Kabi; Grifols, S.A.; Cerus Corporation; Macopharma; CSL Behring; Octapharma AG; Biotest AG; Hemanext Inc.; Cellphire Inc.; American Red Cross; Sanquin; Canadian Blood Services; Vitalant
No. of Pages
327
Segmentation
By Platelet type
Whole-blood Derived Platelets
Apheresis-derived Platelets
By Application
Thrombocytopenia
Platelet Function Disorders
Perioperative Indications
Hematologic / Bleeding Disorders
By End user
Hospitals
Ambulatory Surgical Centers
Other End Users
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
South-east Asia
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of the Middle East and Africa
1. Introduction
1.1. Report Description
1.2. Purpose of the Report
1.3. USP & Key Offerings
1.4. Key Benefits for Stakeholders
1.5. Target Audience
1.6. Report Scope
1.7. Regional Scope 2. Scope and Methodology
2.1. Objectives of the Study
2.2. Stakeholders
2.3. Data Sources
2.3.1. Primary Sources
2.3.2. Secondary Sources
2.4. Market Estimation
2.4.1. Bottom-Up Approach
2.4.2. Top-Down Approach
2.5. Forecasting Methodology 3. Executive Summary 4. Introduction
4.1. Overview
4.2. Key Industry Trends 5. Global Blood Platelets Market
5.1. Market Overview
5.2. Market Performance
5.3. Impact of COVID-19
5.4. Market Forecast 6. Market Breakup by Platelet Type
6.1. Whole-blood Derived Platelets
6.1.1. Market Trends
6.1.2. Market Forecast
6.1.3. Revenue Share
6.1.4. Revenue Growth Opportunity
6.2. Apheresis-derived Platelets
6.2.1. Market Trends
6.2.2. Market Forecast
6.2.3. Revenue Share
6.2.4. Revenue Growth Opportunity 7. Market Breakup by Application
7.1. Thrombocytopenia
7.1.1. Market Trends
7.1.2. Market Forecast
7.1.3. Revenue Share
7.1.4. Revenue Growth Opportunity
7.2. Platelet Function Disorders
7.2.1. Market Trends
7.2.2. Market Forecast
7.2.3. Revenue Share
7.2.4. Revenue Growth Opportunity
7.3. Perioperative Indications
7.3.1. Market Trends
7.3.2. Market Forecast
7.3.3. Revenue Share
7.3.4. Revenue Growth Opportunity
7.4. Hematologic / Bleeding Disorders
7.4.1. Market Trends
7.4.2. Market Forecast
7.4.3. Revenue Share
7.4.4. Revenue Growth Opportunity 8. Market Breakup by End User
8.1. Hospitals
8.1.1. Market Trends
8.1.2. Market Forecast
8.1.3. Revenue Share
8.1.4. Revenue Growth Opportunity
8.2. Ambulatory Surgical Centers
8.2.1. Market Trends
8.2.2. Market Forecast
8.2.3. Revenue Share
8.2.4. Revenue Growth Opportunity
8.3. Other End Users
8.3.1. Market Trends
8.3.2. Market Forecast
8.3.3. Revenue Share
8.3.4. Revenue Growth Opportunity 9. Market Breakup by Region
9.1. North America
9.1.1. United States
9.1.1.1. Market Trends
9.1.1.2. Market Forecast
9.1.2. Canada
9.1.2.1. Market Trends
9.1.2.2. Market Forecast
9.1.3. Mexico
9.1.3.1. Market Trends
9.1.3.2. Market Forecast
9.2. Europe
9.2.1. Germany
9.2.2. France
9.2.3. United Kingdom
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Rest of Asia-Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Argentina
9.4.3. Rest of Latin America
9.5. Middle East and Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa 10. SWOT Analysis
10.1. Overview
10.2. Strengths
10.3. Weaknesses
10.4. Opportunities
10.5. Threats 11. Value Chain Analysis 12. Porters Five Forces Analysis
12.1. Overview
12.2. Bargaining Power of Buyers
12.3. Bargaining Power of Suppliers
12.4. Degree of Competition
12.5. Threat of New Entrants
12.6. Threat of Substitutes 13. Price Analysis 14. Competitive Landscape
14.1. Market Structure
14.2. Key Players
14.3. Profiles of Key Players
14.3.1. Terumo Corporation
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. Financials
14.3.1.4. SWOT Analysis
14.3.2. Fresenius Kabi
14.3.3. Grifols, S.A.
14.3.4. Cerus Corporation
14.3.5. Macopharma
14.3.6. CSL Behring
14.3.7. Octapharma AG
14.3.8. Biotest AG
14.3.9. Hemanext Inc.
14.3.10. Cellphire Inc.
14.3.11. American Red Cross
14.3.12. Sanquin
14.3.13. Canadian Blood Services
14.3.14. Vitalant 15. Research Methodology
Request A Free Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Ready to Transform Data into Decisions?
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Frequently Asked Questions:
What is the market size of the Blood Platelets Market in 2025 and the forecast for 2032?
The Blood Platelets Market was USD 6154.6 million in 2025 and is projected to reach USD 8044.68 million by 2032. The outlook reflects steady growth across transfusion-intensive clinical applications.
What is the CAGR for the Blood Platelets Market during 2025–2032?
The Blood Platelets Market is expected to grow at a CAGR of 3.9% from 2025 to 2032. Growth is supported by sustained platelet use in hematology, oncology, and surgical care.
Which segment is the largest in the Blood Platelets Market?
Apheresis-derived Platelets accounted for the largest share of 52.4% in 2025. Apheresis-derived Platelets benefit from controlled dosing and operational scalability in large blood centers.
What are the key growth factors for the Blood Platelets Market?
Blood Platelets Market growth is driven by thrombocytopenia management demand, perioperative transfusion needs, and modernization of blood processing workflows. Standardization and inventory optimization also support stable purchasing cycles.
Who are the leading companies in the Blood Platelets Market?
Key companies include Terumo Corporation, Fresenius Kabi, Grifols, S.A., Cerus Corporation, and CSL Behring, along with blood service organizations such as American Red Cross. The company landscape spans processing technology providers and large blood service networks.
Which region leads the Blood Platelets Market in 2025?
Asia Pacific led the Blood Platelets Market with 29.1% share in 2025. Growth is supported by population scale, rising procedural volumes, and expanding transfusion infrastructure.
About Author
Shweta Bisht
Healthcare & Biotech Analyst
Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.
The global Biguanides Market size was estimated at USD 18.64 million in 2025 and is expected to reach USD 23.88 million by 2032, growing at a CAGR of 3.6% from 2025 to 2032.
The Alopecia Treatment / Hair Loss Market is projected to grow from USD 3657.5 million in 2025 to an estimated USD 5257.27 million by 2032, with a compound annual growth rate (CAGR) of 5.3% from 2025 to 2032.
The Alzheimer’s Diagnosis and Drugs Market is projected to grow from USD 8,136.6 million in 2025 to an estimated USD 11,487.23 million by 2032, with a compound annual growth rate (CAGR) of 5.1% from 2025 to 2032.
The AI in Telemedicine Market is projected to grow from USD 26,097.5 million in 2025 to an estimated USD 114,293.5 million by 2032, with a compound annual growth rate (CAGR) of 23.50% from 2025 to 2032.
The Adult Malignant Glioma Therapeutics Market is projected to grow from USD 2687.5 million in 2025 to an estimated USD 5337.98 million by 2032, with a compound annual growth rate (CAGR) of 10.3% from 2025 to 2032.
The Acute Bacterial Skin and Skin Structure Infection Market is projected to grow from USD 2,630.06 million in 2025 to an estimated USD 4,478.33 million by 2032, with a compound annual growth rate (CAGR) of 7.9% from 2025 to 2032.
The Acute Agitation and Aggression Treatment Market is projected to grow from USD 2,656.65 million in 2025 to an estimated USD 4,210.49 million by 2032, with a compound annual growth rate (CAGR) of 6.8% from 2025 to 2032.
The biosimulation market size was valued at USD 1,503.4 million in 2018, increased to USD 3,793.2 million in 2024, and is anticipated to reach USD 13,653.2 million by 2032, at a CAGR of 17.54% during the forecast period.
The global Bromelain Products Market size was estimated at USD 45.37 million in 2025 and is expected to reach USD 70.97 million by 2032, growing at a CAGR of 6.6% from 2025 to 2032.
The global Biosimilars Market size was estimated at USD 35,727.22 million in 2025 and is expected to reach USD 88,851.61 million by 2032, growing at a CAGR of 13.9% from 2025 to 2032.
The global Biopharmaceuticals Market size was estimated at USD 457,158.2 million in 2025 and is expected to reach USD 783,488.82 million by 2032, growing at a CAGR of 8% from 2025 to 2032.
Licence Option
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$5999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
